PHYTEX PAINT CUTANEOUS SOLUTION
Active substance(s): BORIC ACID / METHYL SALICYLATE / SALICYLIC ACID / TANNIC ACID
NAME OF THE MEDICINAL PRODUCT
Phytex Paint Cutaneous Solution
QUALITATIVE AND QUANTITATIVE COMPOSITION
Solution contains tannic acid 4.886% w/v, boric acid 3.1245 w/v, salicylates
(as salicylic acid 0.89% w/v and methyl salicylate 0.526% v/v).
A clear, pale straw-coloured cutaneous solution for application to skin and
For the treatment of infections of the skin and nails due to superficial
dermatophytes of Candida.
Posology and method of administration
For adults, including the elderly, and children over five years:
The tincture is painted onto the affected areas morning and evening and after
washing. Several weeks of treatment may be required to prevent relapse.
Children under five years: Contraindicated.
Known sensitivity to any of the ingredients. Do not use in children under five.
Should not be used on broken or inflamed skin, Use in pregnancy.
Special warnings and precautions for use
Do not use for longer than 10 days without consulting a doctor. For use on nail
areas and feet only. Phytex should be used with caution in patients with
impaired circulation and diabetics. Phytex is for topical use only and may be
harmful if taken internally.
Interaction with other medicinal products and other forms of interaction
Pregnancy and lactation
Effects on ability to drive and use machines
Slight stinging may occur on application. Any further discomfort caused by
dryness of the skin may be due to the astringent nature of the product.
Borotannic complex possesses bacteriostatic and fungistatic properties. After
application the solvent evaporates to leave a clear film over the infected area.
Perspiration subsequently dissolves the active complex which ionises
producing a low pH (about 2.0) that is fungicidal. Salicylic acid facilitates
penetration of infected skin.
Salicytic acid and methyl salicylate are absorbed through the skin, however,
the quantities present in Phytex would make the possibility of systemic
salicylate poisoning remote. Unbound boric acid or Tannic acid may be
absorbed through damaged skin. The quantities present in Phytex would
indicate that systemic effects are highly unlikely.
Preclinical safety data
There are no preclinical data of relevance to the prescriber which are
additional to that already included in other sections of the SPC.
List of excipients
Glacial acetic acid
Industrial methylated spirit
Special precautions for storage
Do not store above 25 C. Keep bottle firmly closed.
Nature and contents of container
Amber glass bottle with polypropylene screw cap and applicator brush,
containing 25 ml.
Special precautions for disposal
No special requirements
MARKETING AUTHORISATION HOLDER
QP-services UK Ltd
Office B, 57 High Street
MARKETING AUTHORISATION NUMBER(S)
DATE OF FIRST AUTHORISATION/RENEWAL OF THE
23 March 1984/28 June 2011
DATE OF REVISION OF THE TEXT
28 June 2011
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.